Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection

被引：10

作者：

McElroy, Anita K. ^{[1
,2
,3
,4
]}

Harmon, Jessica R. ^{[1
]}

Flietstra, Timothy ^{[1
]}

Nichol, Stuart T. ^{[1
]}

Spiropoulou, Christina F. ^{[1
]}

机构：

[1] US Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA USA

[2] Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA 30322 USA

[3] Childrens Healthcare Atlanta, Atlanta, GA USA

[4] Univ Pittsburgh, Sch Med, Div Pediat Infect Dis, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2018年 / 218卷 / 11期

基金：

美国国家卫生研究院;

关键词：

Rift Valley fever virus; biomarker; chemokine; inflammation; pathogenesis; CYTOKINE;

D O I：

10.1093/infdis/jiy393

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rift Valley fever virus is an arbovirus found in Africa and the Middle East. Most infected individuals experience a mild self-limiting illness; however, some develop severe disease including hepatitis, hemorrhagic fever, or encephalitis. The biological reasons for these marked differences in disease manifestation are unknown. In this study, we evaluate 32 biomarkers in serum of 26 patients from an outbreak that occurred in Saudi Arabia in 2000-2001. Eleven biomarkers correlated with viral RNA. Thirteen biomarkers were associated with a fatal outcome. No associations of biomarkers and hemorrhage or central nervous system disease were identified in this cohort.

引用

页码：1847 / 1851

页数：5

共 15 条

[1] Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of rift valley fever virus
Bird, Brian H.
Bawiec, Darcy A.
Ksiazek, Thomas G.
Shoemaker, Trevor R.
Nichol, Stuart T.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (11) : 3506 - 3513
[2] Gene of the month: HGF
Fajardo-Puerta, Ana Belen
Prado, Mireia Mato
Frampton, Adam E.
Jiao, Long R.
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (07) : 575 - 579
[3] Shedding of Tumor Necrosis Factor Receptor 1 Induced by Protein A Decreases Tumor Necrosis Factor Alpha Availability and Inflammation during Systemic Staphylococcus aureus Infection
Giai, Constanza
Gonzalez, Cintia
Ledo, Camila
Garofalo, Ailin
Silvia Di Genaro, Maria
Sordelli, Daniel O.
Gomez, Marisa I.
[J]. INFECTION AND IMMUNITY, 2013, 81 (11) : 4200 - 4207
[4] Harmon J, 2018, PLOS NEGLECT TROP D, V12
[5] Association of Symptoms and Severity of Rift Valley Fever with Genetic Polymorphisms in Human Innate Immune Pathways
Hise, Amy G.
Traylor, Zachary
Hall, Noemi B.
Sutherland, Laura J.
Dahir, Saidi
Ermler, Megan E.
Muiruri, Samuel
Muchiri, Eric M.
Kazura, James W.
LaBeaud, A. Desiree
King, Charles H.
Stein, Catherine M.
[J]. PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (03):
[6] Rift Valley fever epidemic in Saudi Arabia: Epidemiological, clinical, and laboratory characteristics
Madani, TA
Al-Mazrou, YY
Al-Jeffri, MH
Mishkhas, AA
Al-Rabeah, AM
Turkistani, AM
Al-Sayed, MO
Abodahish, AA
Khan, AS
Ksiazek, TG
Shobokshi, O
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) : 1084 - 1092
[7] Impaired T cell function in RANTES-deficient mice
Makino, Y
Cook, DN
Smithies, O
Hwang, OY
Neilson, EG
Turka, LA
Sato, H
Wells, AD
Danoff, TM
[J]. CLINICAL IMMUNOLOGY, 2002, 102 (03) : 302 - 309
[8] Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome
McElroy, Anita K.
Erickson, Bobbie R.
Flietstra, Timothy D.
Rollin, Pierre E.
Nichol, Stuart T.
Towner, Jonathan S.
Spiropoulou, Christina F.
[J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (04) : 558 - 566
[9] Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection
McElroy, Anita K.
Nichol, Stuart T.
[J]. VIROLOGY, 2012, 422 (01) : 6 - 12
[10] Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
McEver, Rodger P.
[J]. CARDIOVASCULAR RESEARCH, 2015, 107 (03) : 331 - 339

← 1 2 →